SNPS - Spark Newswire

3 minute read

Infosys (INFY) Boosts Digital Portfolio With BASE Life Buyout

Today, 9:58 AM

Infosys (NYSE: INFY) recently announced that it has signed a definitive agreement to acquire the Denmark-based technology and consulting firm in the life sciences industry – BASE Life Science.

AVGO

1 minute read

Here’s How Much $100 Invested In Synopsys 10 Years Ago Would Be Worth Today

By Benzinga Insights

Today, 9:58 AM

Synopsys (NASDAQ:SNPS) has outperformed the market over the past 10 years by 15.1% on an annualized basis producing an average annual return of 25.9%. Currently, Synopsys has a market capitalization of $46.08 billion.

SNPS

2 minute read

Analyst Downgrades Texas Instruments And Skyworks, Upgrades These 2 Semi Stocks

By Wayne Duggan

Today, 9:58 AM

Semiconductor stocks have taken a big hit so far in 2022, and one Wall Street analyst just adjusted his ratings on six semis heading into the second half of the year. The Analyst: Bank of America analyst Vivek Arya made the following seven ratings changes on Wednesday:

AAPL

1 minute read

B of A Securities Upgrades Synopsys to Neutral, Raises Price Target to $360

By Benzinga Newsdesk

Today, 9:58 AM

B of A Securities analyst Vivek Arya upgrades Synopsys (NASDAQ:SNPS) from Underperform to Neutral and raises the price target from $325 to $360.

SNPS

3 minute read

News

Synopsys And Arm Strengthen Partnership To Advance Next-Gen Mobile SoCs For Arm’s Total Compute Solutions

By Benzinga Newsdesk

Today, 9:58 AM

Enabling mutual customers to deliver specialized compute, high performance and high efficiency for mobile applications including laptops, smartphones, gaming and augmented/virtual reality, Synopsys, Inc.

SNPS

1 minute read

Here’s How Much You Would Have Made Owning Synopsys Stock In The Last 10 Years

By Benzinga Insights

Today, 9:58 AM

Synopsys (NASDAQ:SNPS) has outperformed the market over the past 10 years by 15.2% on an annualized basis producing an average annual return of 27.35%. Currently, Synopsys has a market capitalization of $50.46 billion.

SNPS

1 minute read

Markets Finish Lower Following Wednesday’s Intense Sell-Off

By Henry Khederian

Today, 9:58 AM

U.S. indices finished Thursday's trading session lower. Worse-than-expected retail earnings and anticipation of further Federal Reserve policy tightening in 2022 have continued to weigh on stocks across sectors.

ABT

3 minute read

38 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 9:58 AM

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.

AFI